A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MRSA

Search Conditions:
Search Keyword : MRSA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: MRSA
Appearance Frequency: 19792 time(s)
Long forms: 70

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
methicillin-resistant Staphylococcus aureus
(19694 times)
Communicable Diseases
(3946 times)
MSSA (1760 times)
MIC (854 times)
VRE (805 times)
1976 Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.
DMPPC-resistant S. aureus
(16 times)
Anti-Bacterial Agents
(3 times)
MICs (2 times)
S. aureus (2 times)
ACH (1 time)
1990 [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
methicillin-resistant phenotype
(4 times)
Pathology
(1 time)
CFU (1 time)
CMC (1 time)
HLMR (1 time)
2011 [Egg crater mattresses: a deposit of methicillin-resistant staphylococcus aureus?].
mortality in sufferers.Meticillin-resistant Staphylococcus aureus
(3 times)
Health Services Research
(3 times)
CI (1 time)
OR (1 time)
2013 Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
MR S. aureus
(3 times)
Optometry
(1 time)
MR (3 times)
MSSA (2 times)
CFU (1 time)
2014 Carriage of Staphylococcus species in the veterinary visiting dog population in mainland UK: molecular characterisation of resistance and virulence.
methicillin and oxacillin resistant
(2 times)
Anti-Bacterial Agents
(1 time)
CFU (1 time)
ECg (1 time)
hpf (1 time)
2002 Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia.
Methicillin-resistant and methicillin-susceptible Staphylococcus aureus
(2 times)
Anti-Bacterial Agents
(1 time)
CAPTURE (1 time)
2002 Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
ml for S. aureus
(2 times)
Veterinary Medicine
(1 time)
BWG (1 time)
CLSI (1 time)
FCR (1 time)
2018 Biological activity of Cymbopogon schoenanthus essential oil.
monocytogenes, Staphylococcus aureus
(2 times)
Microbiological Phenomena
(1 time)
HBV (1 time)
MIC (1 time)
2016 Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens.
10  MRSA group
(2 times)
Hip Joint
(1 time)
CRP (1 time)
MSSA (1 time)
2014 Clinical Characteristics of Methicillin-resistant Staphylococcus aureus Infection for Chronic Periprosthetic Hip and Knee Infection.
11  multidrug-resistant
(2 times)
GC-MS (1 time)
MIC (1 time)
PK (1 time)
2014 Chemical Composition, Modulatory Bacterial Resistance and Antimicrobial Activity of Essential Oil the Hyptis martiusii Benth by Direct and Gaseous Contact.
12  multiresistant strains
(2 times)
Biochemistry
(1 time)
Rot (1 time)
2009 An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
13  IntroductionMeticillin-resistant Staphylococcus aureus
(1 time)
Communicable Diseases
(1 time)
--- 2019 Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the Dutch-German border region, 2012 to 2016: results of the search-and-follow-policy.
14  macrolides
(1 time)
Biology
(1 time)
MICs (1 time)
2018 Dolastane diterpenes from Canistrocarpus cervicornis and their effects in modulation of drug resistance in Staphylococcus aureus.
15  majority of oxacillin-resistant
(1 time)
Communicable Diseases
(1 time)
VRE (1 time)
2010 Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).
16  markedly different rates of Staphylococcus aureus
(1 time)
Medicine
(1 time)
HAIs (1 time)
ICU (1 time)
2022 Transient dynamics of infection transmission in a simulated intensive care unit.
17  MDRB isolates
(1 time)
Geriatrics
(1 time)
ESBL-E (1 time)
MDRB (1 time)
VRE (1 time)
2012 Health outcomes of older patients colonized by multi-drug resistant bacteria (MDRB): a one-year follow-up study.
18  mecA to S. aureus
(1 time)
Veterinary Medicine
(1 time)
MALDI-TOF MS (1 time)
MRCNS (1 time)
2011 Prevalence and characteristics of methicillin-resistant coagulase-negative staphylococci from livestock, chicken carcasses, bulk tank milk, minced meat, and contact persons.
19  mechanistic range shift analysis
(1 time)
Environmental Health
(1 time)
--- 2017 A framework for modelling range shifts and migrations: asking when, whither, whether and will it return.
20  membranes of both Gram-positive
(1 time)
Chemistry
(1 time)
HSA (1 time)
2016 Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents.
21  Methicillin and gentamicin resistant strains of Staphylococcus aureus
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1988 In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
22  methicillin susceptible and resistant staphylococcus aureus respectively
(1 time)
Biochemistry
(1 time)
E. coli (1 time)
FCA (1 time)
MIC (1 time)
2018 Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers.
23  methicillin, causes the rise of antibiotic-resistant strains
(1 time)
Veterinary Medicine
(1 time)
AFLP (1 time)
MSSA (1 time)
2004 Staphylococcus aureus: study of genomic similarity of strains isolated in veterinary pathology using amplified fragment length polymorphism (AFLP).
24  methicillin- and cephem-resistant subclones of Staphylococcus aureus
(1 time)
Anti-Bacterial Agents
(1 time)
PBPs (1 time)
1985 Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.
25  methicillin- resistant <i>S. aureus</i>
(1 time)
Medicine
(1 time)
WWTPs (1 time)
2020 Occupational exposure to Staphylococcus aureus in the wastewater treatment plants environment.
26  Methicillin-Resistant &lt;i&gt;S. aureus&lt;/i&gt
(1 time)
Biology
(1 time)
FICI (1 time)
MSSA (1 time)
2021 Synergistic Activity of Lupinifolin in Combinations with Antibiotics Against Staphylococcus aureus.
27  methicillin-resistant phenotype in S. aureus
(1 time)
Antineoplastic Agents
(1 time)
DD (1 time)
MIC (1 time)
OS-MRSA (1 time)
2014 mecA-positive methicillin-sensitive Staphylococcus aureus clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
28  methicillin-resistant Staphylococcus aureus prevalence and outbreaks
(1 time)
Health Services
(1 time)
AMR (1 time)
2007 Development and validation of measures to assess prevention and control of AMR in hospitals.
29  methicillin-sensitive and -resistant S. aureus
(1 time)
Biochemistry
(1 time)
BR (1 time)
CUR (1 time)
DMSO (1 time)
2021 Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
30  Methicillin-susceptible and -resistant
(1 time)
Medicine
(1 time)
cSSSI (1 time)
HDSD (1 time)
2008 A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
31  Methicillinresistant and Biofilm-forming Staphylococcus aureus
(1 time)
Biotechnology
(1 time)
--- 2021 Pentacyclic Triterpenoids as Antibiofilm Agents against Methicillinresistant and Biofilm-forming Staphylococcus aureus (MRSA).
32  methide and 8,11,13-totaratriene-12,13-diol showed potent activities against S. aureus
(1 time)
Chemistry
(1 time)
--- 2010 Syntheses and antibacterial activities of diterpene catechol derivatives with abietane, totarane and podocarpane skeletons against methicillin-resistant Staphylococcus aureus and Propionibacterium acnes.
33  methods for detection of S. aureus resistant to oxacillin
(1 time)
Molecular Biology
(1 time)
SA/MRSA (1 time)
2019 Rapid Methods for Detection of MRSA in Clinical Specimens.
34  methycyllin-resistant Staphylococcus aureus and Staphylococcus epidermidis
(1 time)
Epidemiology
(1 time)
SBP (1 time)
2006 [Sepsis and other serious infection patients treated in department of infectious diseases--in own experiences].
35  methycyllin-susceptible and resistant strains
(1 time)
Dermatology
(1 time)
S. aureus (1 time)
S. pyogenes (1 time)
2021 Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
36  methylrestant cultures
(1 time)
General Surgery
(1 time)
AMP (1 time)
2010 [Resistance to antibiotics of nosocomial cultures of Staphylococcus aureus in surgical departments of Ukraine in 2009 year].
37  METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS
(1 time)
General Surgery
(1 time)
--- 2002 [Risk factors and treatment of methicillin-resistant Staphylococcus aureus infections].
38  MIC values for clinical Staphylococci strains
(1 time)
Chemistry
(1 time)
--- 2013 Synthesis and in vitro antibacterial activity of 5-halogenomethylsulfonyl- benzimidazole and benzotriazole derivatives.
39  microbes especially Staph. aureus, P. aeruginosa, and Staph. aureus
(1 time)
Complementary Therapies
(1 time)
AERc (2 times)
HPX (1 time)
MPO (1 time)
2019 Evaluation of the Biological Effects of Lyophilized Hydrophilic Extract of Rhus coriaria on Myeloperoxidase (MPO) Activity, Wound Healing, and Microbial Infections of Skin Wound Tissues.
40  microgram for Streptococcus pneumoniae and Staphylococcus aureus
(1 time)
Communicable Diseases
(1 time)
MICs (1 time)
1997 Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing.
41  microorganism
(1 time)
Anti-Bacterial Agents
(1 time)
--- 2016 Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?
42  microorganisms including: Staphylococcus aureus
(1 time)
FT-IR (1 time)
MICs (1 time)
MLCs (1 time)
2020 Eco-friendly synthesis of silver nanoparticles by Bacillus subtilis and their antibacterial activity.
43  mild improvement in survival ofmethicillin-resistant Staphylococcus aureus
(1 time)
Chemistry
(1 time)
--- 2021 Repurposing celecoxib analogues as leads for antibiotics.
44  mixed culture with Staphylococcus aureus
(1 time)
Anti-Bacterial Agents
(1 time)
ABK (1 time)
GM (1 time)
NTL (1 time)
1994 [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
45  mL against S. aureus
(1 time)
Biochemistry
(1 time)
MIC (1 time)
2019 In vitro anti-bacterial and time kill evaluation of binuclear tricyclohexylphosphanesilver(I) dithiocarbamates, {Cy3PAg(S2CNRR')}2.
46  mL in the case of resistant Staphylococcus aureus
(1 time)
Biology
(1 time)
AB extracted (1 time)
MIC (1 time)
2021 Enhancement of beta-Glucan Biological Activity Using a Modified Acid-Base Extraction Method from Saccharomyces cerevisiae.
47  mL was sufficient to inhibit the growth of Staphylococcus aureus
(1 time)
Chemical Phenomena
(1 time)
CaSt (1 time)
PCL (1 time)
PLC (1 time)
2021 Development of an Antimicrobial-Coated Absorbable Monofilament Suture from a Medical-Grade Poly(l-lactide-co-epsilon-caprolactone) Copolymer.
48  model Gram-positive
(1 time)
Biocompatible Materials
(1 time)
--- 2020 Controllable hydrogen bonded self-association for the formation of multifunctional antimicrobial materials.
49  Models for Staphylococcus aureus
(1 time)
Chemistry
(1 time)
--- 2022 Comparative Study of Two-Dimensional (2D) vs. Three-Dimensional (3D) Organotypic Kertatinocyte-Fibroblast Skin Models for Staphylococcus aureus (MRSA) Infection.
50  more drug-resistant bacteria especially Staphylococcus aureus
(1 time)
--- 2021 Evaluation of antimicrobial activity of bacterial symbionts isolated from wild field cockroach Blattella vaga from Saudi Arabia.
51  more isolates of SA and SC are resistant to methicillin
(1 time)
Dermatology
(1 time)
cSSSI (1 time)
SA (1 time)
SC (1 time)
2006 Dalbavancin: a review for dermatologists.
52  more readmissions to hospitals
(1 time)
Nursing
(1 time)
CDI (1 time)
ESBL (1 time)
VRE (1 time)
2015 Quantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities.
53  more susceptible to oxacillin, resistance to oxacillin by highly-resistant strains
(1 time)
Neoplasms
(1 time)
CPZ (1 time)
MSSA (1 time)
TZ (1 time)
2006 Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
54  most common bacteria weremethicillin-resistant Staphylococcus aureus
(1 time)
CPR (1 time)
IE (1 time)
MSSA (1 time)
2020 Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population.
55  Most S aureus strains are resistant to methicillin
(1 time)
Communicable Diseases
(1 time)
VRSA (1 time)
2015 Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains isolated from hospital effluents.
56  movements, such as walking, running or swimming
(1 time)
Neurology
(1 time)
HC-3 (1 time)
1980 Effects of hemicholinium-3 and choline on hippocampal electrical activity during immobility vs. movement.
57  MR Staphylococcus aureus
(1 time)
Dermatology
(1 time)
MR (1 time)
MRSP (1 time)
MRSS (1 time)
2010 The prevalence of carriage of meticillin-resistant staphylococci by veterinary dermatology practice staff and their respective pets.
58  MRSA and VRE infection or colonization
(1 time)
Communicable Diseases
(1 time)
CI (1 time)
HAIs (1 time)
HR (1 time)
2009 Exposure to hospital roommates as a risk factor for health care-associated infection.
59  MRSA patients
(1 time)
Communicable Diseases
(1 time)
--- 2007 [Genesis of methicillin-resistant Staphylococcus aureus and selective antibacterial injection pressure].
60  MRSA- and P. aeruginosa-induced nosocomial pneumonia was observed
(1 time)
Communicable Diseases
(1 time)
--- 2001 [Importance of a cleaning in upper airways by using povidone iodine for the prevention of nosocomial pneumonia].
61  MRSA-hVI
(1 time)
Anti-Bacterial Agents
(1 time)
MDRSP (1 time)
2007 In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
62  multi resistant staphylococcus glococcus
(1 time)
Nursing
(1 time)
--- 1987 Occupational health dilemma.
63  multi-drug resistant gram-positive bacteria such as Staphylococcus aureus
(1 time)
Chemistry
(1 time)
--- 2021 Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages.
64  multi-resistant staphylococcus
(1 time)
General Surgery
(1 time)
US (1 time)
2008 Liver abscess in neonates.
65  Multi-species biofilm of Staphylococcus aureus oxacillin resistant
(1 time)
Biomimetics
(1 time)
DFR (1 time)
SSD (1 time)
2015 Anti-biofilm activity of chitosan gels formulated with silver nanoparticles and their cytotoxic effect on human fibroblasts.
66  multidrug resistant pathogenic strains
(1 time)
Biochemistry
(1 time)
MIC (1 time)
ORF (1 time)
WHO (1 time)
2021 Molecular Cloning, Functional and Biophysical Characterization of an Antimicrobial Peptide from Rhizosphere Soil.
67  multidrug-resistant organisms
(1 time)
Rehabilitation
(1 time)
ESBL (1 time)
MDRO (1 time)
2015 [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main District, Germany, 2014: Risk Analysis and Hygiene Procedures].
68  multiple antibiotics, including those resistant to methicillin
(1 time)
Communicable Diseases
(1 time)
--- 1997 Widespread dissemination of epidemic MRSA in German hospitals.
69  multiQACs with superior profiles against resistant
(1 time)
MSSA (1 time)
QACs (1 time)
2015 Bioorganic Investigation of Multicationic Antimicrobials to Combat QAC-Resistant Staphylococcus aureus.
70  muscular vessels-related sympathetic activity
(1 time)
Aerospace Medicine
(1 time)
BP (1 time)
HR (1 time)
PWAO (1 time)
2011 [Effect of strength-building training on manifestation of pressor reflex from working muscles receptors].